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Abstract
We have explored the levels of phosphatidylinositol-3 kinase protein during culture of rat 3Y1 cells. Confluent cell
cultures exhibited a higher level of phosphatidylinositol-3 kinase compared with that of growing cells. After replating of the
cells on fresh dishes, the level of phosphatidylinositol-3 kinase returned to that of growing cells within 24 h. This
density-dependent regulation of the phosphatidylinositol-3 kinase level was not lined to cell growth, because growth arrest
by serum starvation did not cause elevation of the phosphatidylinositol-3 kinase level. Northern blotting analysis revealed
that this regulation was based on the transcriptional level. After cell growth was arrested by contact inhibition, elevation of
the level of phosphatidylinositol-3,4,5-trisphosphate was detected suggesting that phosphatidylinositol-3 kinase was
activated in these cells. These effects were not seen in src-transformed 3Y1 cells, suggesting that this regulation was lost in
transformed cells. q 1998 Elsevier Science B.V.
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1. Introduction
 .Phosphatidylinositol PI -3 kinase is one of the
enzymes involved in signal transduction pathways
induced by growth factors and differentiation factors.
PI-3 kinase catalyzes phosphorylation of PI, PI-4-
 . phosphate PI-4-P , and PI-4,5-bisphosphate PI-4-5-
.P at the D-3 position of the inositol rings to pro-2
 .duce PI-3-phosphate PI-3-P , PI-3,4-bisphosphate
 .  .PI-3,4-P , and PI-3,4,5-trisphosphate PI-3,4,5-P ,2 3
w xrespectively 1,2 . The kinase is activated immedi-
ately upon stimulation by ligands such as growth
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factors or differentiation factors to elevate the levels
w xof PI-3,4-P and PI-3,4,5-P 2–4 . There are at lest2 3
two types of PI-3 kinases: some may be activated by
w xtyrosine kinases 3–14 and others by G protein bg
w xsubunits 15 . Those that are activated by tyrosine
kinases consist of two subunits with molecular sizes
 .  . w xof 85 kDa p85 and 110 kDa p110 16–18 . Both
subunits have isotypes, indicating that there may be a
fine network regulating the PI-3 kinase activity in
intact cells to elicit cell responses to ligand stimula-
w xtion 19–21 .
The mechanisms of activation of PI-3 kinase upon
stimulation of the receptor tyrosine kinases have been
studied in a number of laboratories. One mechanism
is the binding of PI-3 kinase to phosphotyrosine-
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containing proteins through the SH2 domains of p85
w x5 . Activation of PI-3 kinase by binding of tyrosine-
 .phosphorylated IRS insulin receptor substrate 1 or
the autophosphorylation site of the PDGF receptor
w xhas been reported 3,6 . Another mechanism is bind-
ing of the SH3 regions to the proline rich regions of
w xp85 22 . Fyn and lyn proteins may activate PI-3
w xkinase by this mechanism 22 . It has also been
suggested that activated ras proteins can bind and
w xactivate PI-3 kinase 23 . Despite these detailed ex-
periments on the modification of PI-3 kinase, there
are very few reports about its quantitative regulation.
We produced various monoclonal antibodies to p85
w x .24 and this paper and explored the regulation of
p85 levels in cultured cells. We found that levels of
p85s are regulated by cell density during culture and
that this regulation is seen only in non-transformed
cells whose growth is strictly regulated by contact
inhibition.
2. Materials and methods
2.1. Cell culture
 . w x 3Y1 rat fibroblast cells 25 and SR-3Y1 src-
.transformed 3Y1 cells were cultured in DMEM
 .Dubecco’s modified minimal essential medium sup-
plemented with 10% calf serum.
2.2. Western blotting
Samples electrophorased on SDS-polyacrylamide
gels were transferred to a polyvinylidene difluoride
 . PVDF membrane Immobilon-P, Millipore Co.,
.Milford, MA, USA . After preincubation with Tris-
 .buffered saline solution TBS containing 0.1%
Tween 20 and 5% skim milk for at least 1 h, the
membrane was incubated with appropriate antibodies
for 1–3 h, and then with goat anti-mouse IgG anti-
body conjugated with horseradish peroxidase for 1 h.
After washing with TBS containing 0.1% Tween 20,
the bands were visualized with the ECL system
 .Amersham Co., Buckingham, UK .
2.3. Antibodies
 .Monoclonal antibody MAb AB6, specific to the
p85a subunit was produced as described before
w x24,26 . MAb 2B3, specific to p85b, was produced
against GST-fused bovine p85b protein according to
w xthe method previously described 26 . Anti-p110
anti-serum raised against a synthetic peptide corre-
sponding to 72th to 88th amino acid of bovine p110a
was a kind gift from Dr. S. Higashi Meiji College of
.Pharmacy .
2.4. Northern blotting
5mg of total RNA obtained by the guanidine
w xthiocyanate-phenol method 27 was separated on a
1.2% agarose gel containing 2.2 M formaldehyde with
a buffer containing 0.02 M MOPS, pH 7.0, 8 mM
sodium acetate, and 1 mM EDTA, pH 8.0, and trans-
ferred to a nitrocellulose membrane Schleicher and
.Schuell by the capillary method. After fixation by
baking the filter at 808C for 1 h, prehybridization was
carried out in 40% formamide, 5= Denhardt’s solu-
tion, 5=SSPE, 0.1% SDS, and 100 mgrml heat-de-
natured salmon sperm DNA at 378C for more than
6 h. Hybridization was carried out overnight under
the same conditions with 32P-labeled human p85a ,
bovine p85b, bovine p110a , human b-actin, and
human glyceraldehyde 3-phosphate dehydrogenase
 .G3PDH as probes. Membranes were washed 3 times
in a solution containing 0.1% SDS, 2=SSC at 378C
for 20 min.
[32 x2.5. In ˝i˝o labeling of the cells with P -orthophos-
phate and analysis of lipids
For 32P-labeling, the medium was replaced with
phosphate free medium containing 25 mM HEPES–
NaOH, pH 7.4 in the absence of serum. Cells were
w32 x  .incubated with P -orthophosphate 1.0 mCirml for
4 h. Reaction was stopped by adding a solution con-
taining 250 mM NaCl, 1 N HCl, and 50% methanol.
After scraping the cells, lipids were extracted with
equal volume of chloroform. The sample was dried
up and analysis of lipids was performed as described
w xbefore 28 .
3. Results
3.1. The le˝el of p85 is regulated by cell density
The level of p85 was monitored by Western blot-
ting with MAb specific to p85a and p85b. Rat 3Y1
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Fig. 1. Cell density dependent elevation of protein levels of p85s in rat 3Y1 cells. 3Y1 cells were plated at a density of 3=105 cells in
6 cm dishes. Under this condition, the initial cell density appears to be 30% confluency, and the cells completely cover the dish after 2.5
days. Therefore, the cells were still growing on day 2 and cell growth was nearly arrested on day 3. The cell number did not increase after
 .day 4. On days 2, 3, 4, or 5 indicated by the lane numbers in the figure , cells were harvested and lysed. 20 mg of total protein was
 .  .loaded on each lane, and p85s were detected by Western blotting with monoclonal antibodies specific for p85a A and p85b B .
 .Coomassie blue staining of the gel was shown in C . Cells were nearly confluent on day 3 and completely confluent on day 4. Arrows
indicate the immigration positions of p85s.
cells were plated in 6 cm dishes with an initial den-
sity of 3=105 cellsrdish and were cultured until cell
growth was completely arrested by contact inhibition.
As shown in Fig. 1, levels of p85a and b were
elevated after cultivation for 3 to 4 days, when the
cell growth were arrested by cell-to cell contact. This
effect was also seen in another cell line, Swiss 3T3,
which exhibits the tight contact inhibition data not
.shown .
To determine whether this elevation of the p85
level was coupled to cell growth or to cell-to-cell
contact, we tested levels of p85 in cells whose growth
was arrested by serum starvation. As shown in Fig. 2,
cell growth was stopped almost completely after
serum was removed and the level of p85a remained
low even after culture for 3 days, whereas the level in
cells cultured in the presence of 10% serum was
elevated after cell growth was stopped by contact
 .inhibition Fig. 2, days 3 to 5 . These results suggest
that higher levels of PI-3 kinase may be related to
cell-to-cell contact. If this is true, cells released from
contact inhibition by replating in a fresh dish will
exhibit lower levels of PI-3 kinase.
To test this possibility, we replated the cells after
contact inhibition on a fresh dish at a low density. As
shown in Fig. 3 panel A, the level of p85a declined,
reaching the basal level within 24 h. The regulation of
p110 level was also tested. As shown in Fig. 4, the
level of p110 was elevated after cell growth was
arrested by contact inhibition and then declined to the
basal level at 24 h after replating. These results sug-
gest that not only the level of p85 but that of p110
was also regulated in the same way and that the level
of the heterodimer form of PI-3 kinase may be
elevated after contact inhibition. This observation
raises the possibility that the PI-3 kinase level de-
clines by stimulation of the cells by growth factors
which induce another cell cycle. The cells after growth
arrest, whose level of p85a was already elevated,
were stimulated by serum. In this experiment, p85a
 .was maintained at a high level data not shown .
Taken together, the data suggest that the level of
PI-3 kinase is regulated by cell density, probably by
cell-to-cell contact, but not by cell growth.
3.2. p85 le˝el of src-transformed 3Y1 is not regulated
by cell density
Since we predicted that if the level of p85 is
regulated by cell density or by cell-to-cell contact,
which is the typical feature of normal cells, trans-
formed cells might have lost this regulation. We
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Fig. 2. Levels of p85a in growing and non-growing 3Y1 cells.
3Y1 cells were plated at a density of 3=105 cells in 6 cm dishes.
On the following day, one half of the dishes were switched to
serum-free medium. The another half were cultured in the pres-
ence of 10% calf serum. Levels of p85a in the 20 mg protein of
the cell lysates were analyzed by Western blotting and densitom-
 .etry line graph . Cell growth was monitored by quantitating the
 .protein content in each dish bar graph . Cell growth stopped
 .after serum starvation black bars , which did not cause elevation
 .of p85a closed circles . In contrast, elevation of the p85a level
was seen in cells cultured in the presence of 10% calf serum
 . open circles after growth arrest by contact inhibition open
.bars .
tested this possibility with src-transformed 3Y1 SR-
.3Y1 cells. They did not show elevation of the p85
level, even after they reached their final density Fig.
.3, panel B . The level remained unchanged after
 .replating on fresh dishes panel B, 0–24 h . These
results suggest that regulation of the p85 level by cell
contact is absent in transformed cells.
3.3. The le˝el of p85 is regulated at transcriptional
le˝el
To see the mechanism of the elevation of p85, the
messenger RNA levels of p85a , b, and p110a were
analyzed. 5mg of total RNA was probed with b-actin,
G3PDH, and the PI-3 kinase probes. b-actin and
G3PDH were used as controls for relatively con-
stantly expressed genes. As shown in Fig. 5, levels of
b-actin and G3PDH mRNAs were lower in the cells
after growth arrest than in growing cells, supporting
the idea that protein synthesis is lower in the cells
after contact inhibition. In contrast, the mRNA level
Fig. 3. Effect of replating on the levels of p85 in untransformed
and transformed 3Y1 cells. Cells were plated at a low density
 5 5 .3=10 cellsrdish for 3Y1 and 1=10 cells for SR-3Y1 in 6 cm
dishes in the presence of 10% calf serum and cultured for 5 days
 .left halves of the graphs, indicated by 0–120h . Then the cells
were trypsinized and replated to fresh dishes at the low density.
After incubation for the periods shown in the right halves of the
graphs, levels of p85a in the 20 mg protein of the cell lysates
were analyzed by Western blotting and densitometry. Relative
density in each Western blotting was shown. Panel A, elevation
of the p85a level was observed in 3Y1 cells as the cell growth
was arrested by contact inhibition, which corresponded to 96 and
120h. After replating to the fresh dishes at a density of 3=
105 cellrdish, the level of p85a declined and reached the level of
growing cells within 24 h. Panel B, SR-3Y1 cells reached their
full density after cultivation for 3 days, and no increase in cell
numbers was observed. The overgrown cells may have become
detached from the dishes and lost. After replating to fresh dishes,
no change in the level of p85a was observed.
( )S. Daduang et al.rBiochimica et Biophysica Acta 1401 1998 113–120 117
Fig. 4. Regulation of p110 level by cell density. 3Y1 cells were
plated at a density of 3=105 cells in 6 cm dishes. After cultiva-
tion for 5 days, cells were replated to a fresh dish at the density
of 3=105 cellsrdish and were cultured for another day. On day 2
 .  . corresponds to sparse cells , 5 confluent cells , and 6 replated
.cells , cells were harvested and lysed. 20 mg of total protein was
 .  .loaded on each lane, and p110a panel A , and p85a panel B
were detected by Western blotting with anti-p110a or anti-p85a .
of p85a , b and p110a did not change greatly.
Quantitation of mRNA levels of p85s as well as
p110a were also performed by PCR method. Ratio
of mRNA of p85a , p85b, and p110a to b-actin or
G3PDH was about 8, 8, 3 fold higher in the cells
after contact inhibition than in sparse cells, respec-
 .tively data not shown . These results suggest that the
mRNA levels of p85a , p85b, and 110a are rela-
tively higher than those of other house keeping genes
in the cells after contact inhibition. We have also
done the experiments on protein levels using tran
w35 xS -labeled cells. The pulse label experiment re-
vealed that the synthesis of p85 was higher in conflu-
ent cells than in sparse cells on the bases of total
protein synthesis supporting the result of northern
 .blotting analysis data not shown . We have also
done the pulse chase experiment. The result indicated
that the degradation rate of p85 was virtually the
same in the growing cells and in the cells after
 .contact inhibition data not shown .
3.4. Ele˝ation of PI-3,4,5-P le˝el in the cells after3
contact inhibition
To see the significance of elevation of the protein
level of PI-3 kinase, activation of PI-3 kinase was
monitored by analyzing the lipid content in confluent
cells. As shown in Fig. 6, the level of PI-3,4,5-P was3
elevated in the cells kept for 3 days after confluency
than in growing cells. The level of PI-3,4-P was2
slightly higher after contact inhibition, however, ele-
vation of levels of other lipids such as PI-3-P, PI-4,5-
 .P or PI-4-P was not detected data not shown . No2
Fig. 5. Northern blotting of p85 and p110 mRNAs from confluent and growing 3Y1 cells. Cells were plated at the density of 1=106
 .  .  .cellsrdish in 10 cm dishes. After incubation for 1 lanes 1 , 5 lanes 2 , or 6 lanes 3 days, RNA was prepared from the cells. Messenger
 .  .  .  .  .RNA levels of p85a panel A , p85b panel B , p110a panel C , b-actin panel D , and G3PDH panel E genes were analyzed by
Northern blotting using 5mg total RNA. Arrowheads indicate the positions of ribosomal RNAs. On day 3, the culture become confluent.
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Fig. 6. Elevation of PI-3,4,5-P level in 3Y1 cells after contact3
inhibition. Cells were plated at 3=105 cellsrdish in 6 cm dishes.
 .  .After incubation for 1 panel A, sparse or 3 panel B, confluent
w32 x  .days, cells were labeled with P -orthophosphate 1 mCirml
for 4 h. The lipid bearing 5=106 count per minute was deacy-
lated and the resulting products were analyzed by high perfor-
 .mance liquid chromatography with SAX5 column Whatmann .
Glycero-PI-3,4-P and glycero-PI-3,4,5-P eluted at 65 min and2 3
86 min, respectively. They are indicated as PI-3,4-P and PI-2
3,4,5-P in the figure. Lipid levels are presented as the ratio of3
the counts in each peak to that of the total lipid. Ratio of
PI-3,4-P and PI-3,4,5-P counts to the sum of PI-4-P and2 3
PI-4,5-P counts were 0.39 and 0.04% in sparse cells and 0.402
and 0.28% in the cells after cell-to-cell contact.
significant elevation of PI-3,4-P or PI-3,4,5-P level2 3
 .was detected in SR-3Y1 cells data not shown .
These results suggest that PI-3 kinase is activated in
the cells after contact inhibition in some way.
4. Discussion
We have demonstrated that the level of PI-3 kinase
was elevated in rat 3Y1 cells after contact inhibition.
The effect was independent of cell growth, but was
closely related to cell density. This regulation was
also seen in Swiss 3T3 cells, whose growth was
strictly regulated by cell-to-cell contact data not
.shown . In contrast, src-transformed 3Y1 cells did
not show this effect, suggesting that the regulation
was lost by cell transformation. In addition, when
3Y1 cells were maintained at a high density for
sometime, cells whose contact inhibition were not
clear appeared spontaneously. These cells did not
 .show elevation of the p85 level data not shown ,
suggesting that cells lacking the capability for strict
contact inhibition lost the regulation of the PI-3
kinase level. Serunian et al. have shown that the
levels of PI-3 kinase products were higher in growing
w xcells than confluent cells in NIH3T3 cells 29 . In our
hands, accumulation of PI-3 kinase after cell-to-cell
 .contact was not seen data not shown . It is widely
known that contact inhibition in NIH3T3 cells is
loose. The regulation of the PI-3 kinase activity in
these cells may be different from that of 3Y1 cells. It
appears that PI-3 kinase accumulates only when cell
growth is strictly arrested by cell-to-cell contact.
The elevation of the PI-3 kinase level was due to
regulation of the transcriptional level. After cell
growth was arrested by contact inhibition, mRNA
levels of b-actin and G3PDH were decreased, indi-
cating that the total protein synthesis may be re-
pressed after cell growth was arrested by cell-to-cell
contact. In contrast, mRNA levels of p85a , b, and
p110a were maintained at the levels of growing cells
even after transcription of these house keeping genes
were suppressed. These results suggest that produc-
tion of PI-3 kinase in the confluent cells are relatively
higher than the most of the other proteins leading to
the accumulation of PI-3 kinase. Because it may take
some time for the relatively stable proteins to be
degraded after contact inhibition, it is conceivable
that elevation of PI-3 kinase is relatively slow.
There is increasing evidence that cells may receive
signals from the extracellular matrix or from other
cells. For example, signal transduction through the
w xintegrins has been reported 30,31 . There may be
pathways to the nucleus via FAK tyrosine kinase,
Ras, MAP kinase, or phospholipase C for regulation
w xof gene expression 31–34 . Although the signaling
pathway by cell-to-cell contact is not known, it is
possible that there are some signal transduction sys-
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tems that down-regulate the transcription of most of
the genes to slow down the metabolism when the cell
density is high. The mechanism of this regulation is
not known; however, it is clear that PI-3 kinase genes
are excluded from this down-regulation to maintain a
high level of transcription even after cell growth are
arrested. It is of interest to explore how this regula-
tion is accomplished.
The reason for the elevation of the PI-3 kinase
level after contact inhibition is not clear. One possi-
bility is that a high level of PI-3 kinase is required for
contact inhibition. Indeed, we detected elevation of
the PI-3,4,5-P level after cell growth was arrested by3
contact inhibition. Recently, activation of PI-3 kinase
w xby stimulation of integrin has been reported 35,36 .
It is possible that PI-3 kinase is also involved in the
signaling pathway of cell-to-cell contact. There is
evidence that PI-3 kinase is required for rearrange-
w xment of the cytoskeleton 30,31 . For example, PI-3
kinase associates with integrin-regulated cytoskeletal
w xcomplexes in platelets 37 . It is interesting to specu-
late that PI-3 kinase plays a role in growth arrest by
cell-to-cell contact by regulating the organization of
the cytoskeleton. Further study may be required for
an understanding of the physiological meaning of the
regulation of PI-3 kinase expression described in this
paper.
Acknowledgements
This work was supported by Grants-in-Aid
a07456046, a07279212, and a07283209, for Scien-
tific Research, the Ministry of Education, Culture and
Science, Japan.
References
w x1 M. Whitman, C.P. Downes, M. Keeler, T. Keller, L. Cant-
 .ley, Nature 332 1988 644–646.
w x2 K.R. Auger, C.L. Carpenter, L.C. Cantley, L. Varticovski, J.
 .Biol. Chem. 264 1989 20181–20184.
w x3 N.B. Ruderman, R. Kapeller, M.F. White, L.C. Cantley,
 .Proc. Natl. Acad. Sci. U.S.A. 87 1990 1411–1415.
w x4 L. Varticovski, B. Druker, D. Morrison, L. Cantley, T.
 .Roberts, Nature 342 1989 699–702.
w x5 D.R. Kaplan, M. Whitman, B. Schaffhausen, D.C. Pallas,
 .M. White, L. Cantley, T.M. Roberts, Cell 50 1987 1021–
1029.
w x6 G. Endemann, K. Yonezawa, R.A. Roth, J. Biol. Chem. 265
 .1990 396–400.
w x7 M. Reedijk, X.Q. Liu, T. Pawson, Mol. Cell. Biol. 10
 .1990 5601–5608.
w x8 S.A. Shurtleff, J.R. Downing, C.O. Rock, S.A. Hawkins,
 .M.F. Roussel, C.J. Sherr, EMBO J. 9 1990 2415–2421.
w x9 J.D. Bjorge, T.O. Chan, M. Antczak, H.J. Kung, D.J. Fujita,
 .Proc. Natl. Acad. Sci. U.S.A. 87 1990 3816–3820.
w x10 A. Graziani, D. Gramaglia, L.C. Cantley, P.M. Comoglio, J.
 .Biol. Chem. 266 1991 22087–22090.
w x11 Y. Fukui, S. Kornbluth, S.-M. Jong, L.-H. Wang, H. Hana-
 .fusa, Oncol. Res. 4 1989 283–292.
w x  .12 Y. Fukui, A.R. Saltiel, H. Hanafusa, Oncogene 6 1991
407–411.
w x  .13 Y. Fukui, H. Hanafusa, Mol. Cell. Biol. 9 1989 1651–1658.
w x14 J.S. Gutkind, P.M. Lacal, K.C. Robbins, Mol. Cell. Biol. 10
 .1990 3806–3809.
w x15 L. Stephens, A. Smrcka, F.T. Cooke, T.R. Jackson, P.C.
 .Sternweis, P.T. Hawkins, Cell 77 1994 83–93.
w x16 S.J. Morgan, A.D. Smith, P.K. Parker, Eur. J. Biochem. 265
 .1990 19704–19711.
w x17 C.L. Carpenter, B.C. Duckworth, K.R. Auger, B. Cohen,
 .B.S. Schaffhausen, L.C. Cantley, J. Biol. Chem. 265 1990
19704–19711.
w x18 F. Shibasaki, Y. Homma, T. Takenawa, J. Biol. Chem. 266
 .1991 8108–8114.
w x19 G. Panayotou, B. Bax, I. Gout, M. Federwisch, B.
Wroblowski, R. Dhand, M.J. Fry, T.L. Blundell, A. Wollmer,
 .M.D. Waterfield, EMBO J. 11 1992 4261–4272.
w x20 K. Baltensperger, L.M. Kozma, S.R. Jaspers, M.P. Czech, J.
 .Biol. Chem. 269 1994 28937–28946.
w x  .21 P. Hu, J. Schlessinger, Mol. Cell. Biol. 14 1994 2577–
2583.
w x22 C.M. Pleiman, W.M. Hertz, J.C. Cambier, Science 263
 .1994 1609–1612.
w x23 T. Kodaki, R. Woscholski, B. Hallberg, P. Rodriguezvi-
 .ciana, L. Downward, P.J. Parker, Curr. Biol. 4 1994
798–806.
w x24 S. Tanaka, M. Matsuda, S. Nagata, T. Kurata, K. Na-
gashima, Y. Shizawa, Y. Fukui, Jpn. J. Cancer Res. 84
 .1993 279–289.
w x25 M.M. Chou, J.E. Fajardo, H. Hanafusa, Mol. Cell. Biol. 12
 .1992 5834–5842.
w x26 S. Nagata, K. Yamamaoto, Y. Ueno, T. Kurata, J. Chiba,
 .Hybridoma 10 1991 369–378.
w x27 R.J. MacDonald, G.H. Swift, A.E. Przybyla, J.M. Chirgwin,
 .Methods Enzymol. 152 1987 219–227.
w x28 K. Kimura, S. Miyake, M. Makuuchi, R. Morita, T. Usui,
M. Yoshida, S. Horinouchi, Y. Fukui, Biosci. Biotech.
 .Biochem. 59 1995 678–682.
w x29 L.A. Serunian, K.R. Auger, T.M. Roberts, L.C. Cantley, J.
 .Virol. 64 1990 4718–4725.
w x  .30 A. Richardson, J.T. Parsons, Bioessays 17 1995 229–236.
w x  .31 E.A. Clark, J.S. Brugge, Science 268 1995 233–239.
( )S. Daduang et al.rBiochimica et Biophysica Acta 1401 1998 113–120120
w x  .32 D.E. Clapham, Cell 80 1995 259–268.
w x33 F.P. Lindberg, D.M. Lublin, M.J. Telen, R.A. Veile, Y.E.
Miller, H. Donis-keller, E.J. Brown, J. Biol. Chem. 269
 .1994 1567–1570.
w x34 S. Kanner, L. Grosmaire, J. Ledbetter, N. Damle, Proc. Natl.
 .Acad. Sci. U.S.A. 90 1993 7099–7103.
w x  .35 K. Vuori, E. Ruoslahti, Science 266 1994 1576–1578.
w x36 H.C. Chen, J.L. Guan, Proc. Natl. Acad. Sci. U.S.A. 91
 .1994 10148–10152.
w x37 J. Zhang, W.G. King, S. Dillon, A. Hall, L. Feig, S.E.
 .Rittenhouse, J. Biol. Chem. 268 1993 22251–22254.
